Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?

Virus Evolution

Volumn 1, Issue 1, 2015, Pages

  Bull, J J ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

R0; Synthetic biology; Virus

Indexed keywords

EID: 84973277954     PISSN: None     EISSN: 20571577     Source Type: Journal    
DOI: 10.1093/ve/vev005     Document Type: Article

References (71)

1. Adams, S. T. M. et al. (2012) 'Common Variable Immunodeficiency Presenting with Persistent Parvovirus B19 Infection', Pediatrics, 130: e1711-5.
2. Antia, R. et al. (2003) 'The Role of Evolution in the Emergence of Infectious Diseases', Nature, 426: 658-61.
3. Atkinson, N. J. et al. (2014) 'The Influence of CpG and UpA Dinucleotide Frequencies on RNA Virus Replication and Characterization of the Innate Cellular Pathways Underlying Virus Attenuation and Enhanced Replication', Nucleic Acids Research, 42: 4527-45.
4. Badgett, M. R. et al. (2002) 'Evolutionary Dynamics of Viral Attenuation', Journal of Virology, 76: 10524-9.
5. Ball, L. A. et al. (1999) 'Phenotypic Consequences of Rearranging the P, M, and G Genes of Vesicular Stomatitis Virus', Journal of Virology, 73: 4705-12.
6. Baric, R. S. et al. (1999) 'Persistent Infection Promotes Cross-Species Transmissibility of Mouse Hepatitis Virus', Journal of Virology, 73: 638-49.
7. Berkhout, B. et al. (1999) 'Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains', Journal of Virology, 73: 1138-45.
8. Bull, J. J., Molineux I. J., and Wilke C. O. (2012) 'Slow Fitness Recovery in a Codon-Modified Viral Genome', Molecular Biology and Evolution, 29: 2997-3004.
9. Bull, J. J., Molineux I. J., and Wilke C. O. (2003) 'Experimental Evolution Yields Hundreds of Mutations in a Functional Viral Genome', Journal of Molecular Evolution, 57: 241-8.
10. Burns, C. C. et al. (2006) 'Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region', Journal of Virology, 80: 3259-72.
11. Burns, C. C. et al. (2009) 'Genetic Inactivation of Poliovirus Infectivity by Increasing the Frequencies of CpG and UpA Dinucleotides within and across Synonymous Capsid Region Codons', Journal of Virology, 83: 9957-69.
12. Burns, C. C. et al. (2014) 'Vaccine-Derived Polioviruses', The Journal of Infectious Diseases, 210(Suppl 1): S283-93.
13. Cecchini, N. et al. (2013) 'Evolutionarily Stable Attenuation by Genome Rearrangement in a Virus', G3 (Bethesda, MD), 3: 1389-97.
14. Chao, L. (1990) 'Fitness of RNA Virus Decreased by Muller's Ratchet', Nature, 348: 454-5.
15. Chroboczek, J., Szurgot I., and Szolajska E. (2014) 'Virus-Like Particles as Vaccine', Acta Biochimica Polonica, 61: 531-9.
16. Coleman, J. R. et al. (2008) 'Virus Attenuation by Genome-Scale Changes in Codon Pair Bias', Science, 320: 1784-7.
17. Depledge, D. P. et al. (2014) 'Deep Sequencing of Viral Genomes Provides Insight into the Evolution and Pathogenesis of Varicella Zoster Virus and Its Vaccine in Humans', Molecular Biology and Evolution, 31: 397-409.
18. DeVries, A. S. et al. (2011) 'Vaccine-Derived Poliomyelitis 12 Years After Infection in Minnesota', The New England Journal of Medicine, 364: 2316-23.
19. Domingo-Calap, P., Cuevas J. M., and Sanjuan R. (2009) 'The Fitness Effects of Random Mutations in Single-Stranded DNA and RNA Bacteriophages', PLoS Genetics, 5: e1000742.
20. Elena, S. F. et al. (2001) 'Transmission Bottlenecks and the Evolution of Fitness in Rapidly Evolving RNA Viruses', Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 1: 41-8.
21. Endy, D. et al. (2000) 'Computation, Prediction, and Experimental Tests of Fitness for Bacteriophage T7 Mutants with Permuted Genomes', Proceedings of the National Academy of Sciences of the United States of America, 97: 5375-80.
22. Enjuanes, L. et al. (2008) 'Vaccines to Prevent Severe Acute Respiratory Syndrome Coronavirus-Induced Disease', Virus Research, 133: 45-62.
23. Farrington, C. P., and Grant A. D. (1999) 'The Distribution of Time to Extinction in Subcritical Branching Processes: Applications to Outbreaks of Infectious Disease', J. Applied Probability, 36: 771-9.
24. Fenner, F., and Cairns J. (1959) 'Variation in Virulence in Relation to Adaptation to New Hosts', in Burnet, F.M., and Stanley,W.M. (eds) The Viruses, Vol. 3. Animal Viruses, pp. 225-249, Academic Press, NewYork, NY.
25. Flanagan, E. B. et al. (2001) 'Rearrangement of the Genes of Vesicular Stomatitis Virus Eliminates Clinical Disease in the Natural Host: New Strategy for Vaccine Development', Journal of Virology, 75: 6107-14.
26. Giaever, G., and Nislow C. (2014) 'The Yeast Deletion Collection: A Decade of Functional Genomics', Genetics, 197: 451-65.
27. Groisman, E. A., and Ochman H. (1996) 'Pathogenicity Islands: Bacterial Evolution in Quantum Leaps', Cell, 87: 791-4.
28. Hanley, K. A. (2011) 'The Double-Edged Sword: How Evolution can Make or Break a Live-Attenuated Virus Vaccine', Evolution, 4: 635-43.
29. Harcombe, W. R., Springman R., and Bull J. J. (2009) 'Compensatory Evolution for a Gene Deletion is Not Limited to Its Immediate Functional Network', BMC Evolutionary Biology, 9: 106.
30. Kelly, J. K. et al. (2003) 'Linking Dynamical and Population Genetic Models of Persistent Viral Infection', The American Naturalist, 162: 14-28.
31. Kenney, J. L. et al. (2011) 'Stability of RNA Virus Attenuation Approaches', Vaccine, 29: 2230-4.
32. Kew, O. M. (2012) 'Reaching the Last One Per Cent: Progress and Challenges in Global Polio Eradication', Current Opinion in Virology, 2: 188-98.
33. Lamirande, E. W. et al. (2008) 'A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus is Immunogenic and Efficacious in Golden Syrian Hamsters', Journal of Virology, 82: 7721-4.
34. Lauring, A. S., Jones J. O., and Andino R. (2010) 'Rationalizing the Development of Live Attenuated Virus Vaccines', Nature Biotechnology, 28: 573-9.
35. Lee, S.-W. et al. (2012) 'Attenuated Vaccines can Recombine to Form Virulent Field Viruses', Science, 337: 188.
36. Lee, S.-W. et al. (2015) 'Growth Kinetics and Transmission Potential of Existing and Emerging Field Strains of Infectious Laryngotracheitis Virus', PloS One, 10: e0120282.
37. Licis, N., and van Duin J. (2006) 'Structural Constraints and Mutational Bias in the Evolutionary Restoration of a Severe Deletion in RNA Phage MS2', Journal of Molecular Evolution, 63: 314-29.
38. Licis, N., and van Duin J. (2000) 'Forced Retroevolution of an RNA Bacteriophage', Virology, 271: 298-306.
39. Liu, M. A. (2011) 'DNA Vaccines: An Historical Perspective and View to the Future', Immunological Reviews, 239: 62-84.
40. Lowen, A. C. et al. (2005) 'Attenuation of Bunyavirus Replication by Rearrangement of Viral Coding and Noncoding Sequences', Journal of Virology, 79: 6940-6.
41. Martrus, G. et al. (2013) 'Changes in Codon-Pair Bias of Human Immunodeficiency Virus Type 1 have Profound Effects on Virus Replication in Cell Culture', Retrovirology, 10: 78.
42. Mazel-Sanchez, B., and Elliott R. M. (2012) 'Attenuation of Bunyamwera Orthobunyavirus Replication by Targeted Mutagenesis of Genomic Untranslated Regions and Creation of Viable Viruses with Minimal Genome Segments', Journal of Virology, 86: 13672-8.
43. Meng, J. et al. (2014) 'Refining the Balance of Attenuation and Immunogenicity of Respiratory Syncytial Virus by Targeted Codon Deoptimization of Virulence Genes', mBio, 5: e01704-14.
44. Michelfelder, S., and Trepel M. (2009) 'Adeno-Associated Viral Vectors and Their Redirection to Cell-Type Specific Receptors', Advances in Genetics, 67: 29-60.
45. Mourez, T. et al. (2011) 'A Chimeric Measles Virus with a Lentiviral Envelope Replicates Exclusively in CD4+/CCR5+ Cells', Virology, 419: 117-25.
46. Mueller, S. et al. (2006) 'Reduction of the Rate of Poliovirus Protein Synthesis through Large-Scale Codon Deoptimization Causes Attenuation of Viral Virulence by Lowering Specific Infectivity', Journal of Virology, 80: 9687-96.
47. Mueller, S. et al. (2010) 'Live Attenuated Influenza Virus Vaccines by Computer-Aided Rational Design', Nature Biotechnology, 28: 723-6.
48. Nathanson, N., and Kew O. M. (2010) 'From Emergence to Eradication: the Epidemiology of Poliomyelitis Deconstructed', American Journal of Epidemiology, 172: 1213-29.
49. Ni, Y.-Y. et al. (2014) 'Computer-Aided Codon-Pairs Deoptimization of the Major Envelope GP5 Gene Attenuates Porcine Reproductive and Respiratory Syndrome Virus', Virology, 450-451: 132-9.
50. Nichols, R. J. et al. (2011) 'Phenotypic Landscape of a Bacterial Cell', Cell, 144: 143-56.
51. Nogales, A. et al. (2014) 'Influenza A Virus Attenuation by Codon Deoptimization of the NS Gene for Vaccine Development', Journal of Virology, 88: 10525-40.
52. Nougairede, A. et al. (2013) 'Random Codon Re-Encoding Induces Stable Reduction of Replicative Fitness of Chikungunya Virus in Primate and Mosquito Cells', PLoS Pathogens, 9: e1003172.
53. Noun, C. L. et al. (2014) 'Attenuation of Human Respiratory Syncytial Virus by Genome-Scale Codon-Pair Deoptimization', Proceedings of the National Academy of Sciences of the United States of America, 111: 13169-74.
54. Novella, I. S., Ball L. A., andWertz G. W. (2004) 'Fitness Analyses of Vesicular Stomatitis Strains with Rearranged Genomes Reveal Replicative Disadvantages', Journal of Virology, 78: 9837-41.
55. Onodera, S. et al. (1998) 'Directed Changes in the Number of Double-Stranded RNA Genomic Segments in Bacteriophage phi6', Proceedings of the National Academy of Sciences of the United States of America, 95: 3920-4.
56. Parrish, C. R. (2010) 'Structures and Functions of Parvovirus Capsids and the Process of Cell Infection', Current Topics in Microbiology and Immunology, 343: 149-76.
57. Pena, L. et al. (2013) 'Influenza Viruses with Rearranged Genomes as Live-Attenuated Vaccines', Journal of Virology, 87: 5118-27.
58. Petro, C. et al. (2015) 'Herpes Simplex Type 2 Virus Deleted in Glycoprotein D Protects against Vaginal, Skin and Neural Disease', eLife, 4: e06054.
59. Reimann, I. et al. (2004) 'An Avirulent Chimeric Pestivirus with Altered Cell Tropism Protects Pigs against Lethal Infection with Classical Swine Fever Virus', Virology, 322: 143-57.
60. Rocha, E. P. C. (2008) 'The Organization of the Bacterial Genome', Annual Review of Genetics, 42: 211-33.
61. Rokyta, D. et al. (2002) 'Experimental Genomic Evolution: Extensive Compensation for Loss of DNA Ligase Activity in a Virus', Molecular Biology and Evolution, 19: 230-8.
62. Sanjuan, R., Moya A., and Elena S. F. (2004) 'The Distribution of Fitness Effects Caused by Single-Nucleotide Substitutions in an RNA Virus', Proceedings of the National Academy of Sciences of the United States of America, 101: 8396-401.
63. Snchez-Sampedro, L. et al. (2015) 'The Evolution of Poxvirus Vaccines', Viruses, 7: 1726-803.
64. Springman, R. et al. (2005) 'Gene Order Constrains Adaptation in Bacteriophage T7', Virology, 341: 141-52.
65. Todd, D. et al. (2003) 'Investigation of the Unstable Attenuation Exhibited by a Chicken Anaemia Virus Isolate', Avian Pathology, 32: 375-82.
66. Troy, S. B. et al. (2014) 'Community Circulation Patterns of Oral Polio Vaccine Serotypes 1, 2, and 3 After Mexican National Immunization Weeks', The Journal of Infectious Diseases, 209: 1693-9.
67. Tulloch, F. et al. (2014) 'RNA Virus Attenuation by Codon Pair Deoptimisation is an Artefact of Increases in CpG/UpA Dinucleotide Frequencies', eLife, 3: e04531.
68. Wang, B. et al. (2015) 'Recoding of the Vesicular Stomatitis Virus L Gene by Computer-Aided Design Provides a Live, Attenuated Vaccine Candidate', mBio, 6: e00237-15.
69. Wertz, G. W., Perepelitsa V. P., and Ball L. A. (1998) 'Gene Rearrangement Attenuates Expression and Lethality of a Nonsegmented Negative Strand RNA Virus,' Proceedings of the National Academy of Sciences of the United States of America, 95: 3501-6.
70. Whatmore, A. M. et al. (1995) 'Repair and Evolution of nef In Vivo Modulates Simian Immunodeficiency Virus Virulence,' Journal of Virology, 69: 5117-23.
71. Yamanaka, A., Suzuki R., and Konishi E. (2014) 'Evaluation of Single-Round Infectious, Chimeric Dengue Type 1 Virus as an Antigen for Dengue Functional Antibody Assays,' Vaccine, 32: 4289-95.